{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T06:12:40Z","timestamp":1757311960484},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,7,16]],"date-time":"2020-07-16T00:00:00Z","timestamp":1594857600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,7,16]],"date-time":"2020-07-16T00:00:00Z","timestamp":1594857600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>To determine levels of change in risk factors for cardiovascular disease among people with and without a previous diagnosis of diabetes from 2007 to 2016 in Iran. Data were obtained from five rounds of the World Health Organization STEPwise approach to Surveillance (STEPS) cross-sectional surveys. Participants were 7665 and 93,733 adults with and without known diabetes, respectively, aged 25\u201365\u00a0years. We used logistic and linear regressions to assess the trends of risk factors. Individuals with known diabetes compared to those without the condition, experienced greater reductions in mean levels of systolic blood pressure (3.0 vs. 0.5\u00a0mmHg among women and 3.9 vs. 1.6\u00a0mmHg among men), diastolic blood pressure (6.4 vs. 5.11\u00a0mmHg in women and 3.3 vs. 1.8\u00a0mmHg in men), and non-HDL cholesterol (42.4 vs. 27.2\u00a0mg\/dL among women and 30.3 vs. 21.0\u00a0mg\/dL among men) throughout these years. Men with diabetes also showed a greater reduction in the prevalence of daily cigarette smoking compared to their non-diabetic counterparts (7.3% vs. 2.3%). Fasting plasma glucose decreased among subjects with diabetes but increased among those without diabetes. Significant increases were observed in proportions who met goals for blood pressure, triglycerides, non-HDL cholesterol and LDL cholesterol in both groups; however, almost half of diabetic subjects did not achieve risk factor goals in 2016. Secondary prevention in diabetic patients was more effective than primary prevention in the general population; however, the rate of diabetic patients who met the designated goals for each risk factor was still suboptimal.<\/jats:p>","DOI":"10.1038\/s41598-020-68640-9","type":"journal-article","created":{"date-parts":[[2020,7,16]],"date-time":"2020-07-16T10:02:53Z","timestamp":1594893773000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Trends in cardiovascular risk factors in diabetic patients in comparison to general population in Iran: findings from National Surveys 2007\u20132016"],"prefix":"10.1038","volume":"10","author":[{"given":"Hamid","family":"Malekzadeh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mojtaba","family":"Lotfaliany","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Afshin","family":"Ostovar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Farzad","family":"Hadaegh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fereidoun","family":"Azizi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Moein","family":"Yoosefi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Farshad","family":"Farzadfar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Davood","family":"Khalili","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,7,16]]},"reference":[{"key":"68640_CR1","doi-asserted-by":"publisher","first-page":"1987","DOI":"10.2337\/dc16-0614","volume":"39","author":"JM Baena-D\u00edez","year":"2016","unstructured":"Baena-D\u00edez, J. M. et al. Risk of cause-specific death in individuals with diabetes: a competing risks analysis. Diabetes Care 39, 1987\u20131995. https:\/\/doi.org\/10.2337\/dc16-0614 (2016).","journal-title":"Diabetes Care"},{"key":"68640_CR2","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1136\/bmj.317.7160.703","volume":"317","author":"U. K. Prospective Diabetes Study Group","year":"1998","unstructured":"U. K. Prospective Diabetes Study Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group. BMJ 317, 703\u2013713 (1998).","journal-title":"BMJ"},{"key":"68640_CR3","doi-asserted-by":"publisher","first-page":"1795","DOI":"10.1161\/CIRCULATIONAHA.115.017926","volume":"132","author":"A Pan","year":"2015","unstructured":"Pan, A., Wang, Y., Talaei, M. & Hu, F. B. Relation of smoking with total mortality and cardiovascular events among patients with diabetes mellitus: a meta-analysis and systematic review. Circulation 132, 1795\u20131804. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.115.017926 (2015).","journal-title":"Circulation"},{"key":"68640_CR4","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1038\/nrcardio.2011.23","volume":"8","author":"DJ Betteridge","year":"2011","unstructured":"Betteridge, D. J. Lipid control in patients with diabetes mellitus. Nat. Rev. Cardiol. 8, 278\u2013290. https:\/\/doi.org\/10.1038\/nrcardio.2011.23 (2011).","journal-title":"Nat. Rev. Cardiol."},{"key":"68640_CR5","doi-asserted-by":"publisher","first-page":"2005","DOI":"10.1016\/s0140-6736(03)13636-7","volume":"361","author":"R Collins","year":"2003","unstructured":"Collins, R. et al. MRC\/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial. Lancet 361, 2005\u20132016. https:\/\/doi.org\/10.1016\/s0140-6736(03)13636-7 (2003).","journal-title":"Lancet"},{"key":"68640_CR6","doi-asserted-by":"publisher","first-page":"1755","DOI":"10.1016\/s0140-6736(98)04311-6","volume":"351","author":"L Hansson","year":"1998","unstructured":"Hansson, L. et al. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group. Lancet 351, 1755\u20131762. https:\/\/doi.org\/10.1016\/s0140-6736(98)04311-6 (1998).","journal-title":"Lancet"},{"key":"68640_CR7","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.2337\/dc05-2465","volume":"29","author":"J Shepherd","year":"2006","unstructured":"Shepherd, J. et al. Effect of lowering LDL cholesterol substantially below currently recommended levels in patients with coronary heart disease and diabetes: the Treating to New Targets (TNT) study. Diabetes Care 29, 1220\u20131226. https:\/\/doi.org\/10.2337\/dc05-2465 (2006).","journal-title":"Diabetes Care"},{"key":"68640_CR8","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.1056\/NEJMsa1213829","volume":"368","author":"MK Ali","year":"2013","unstructured":"Ali, M. K. et al. Achievement of goals in U.S. diabetes care, 1999\u20132010. N. Engl. J. Med. 368, 1613\u20131624. https:\/\/doi.org\/10.1056\/NEJMsa1213829 (2013).","journal-title":"N. Engl. J. Med."},{"key":"68640_CR9","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1001\/jama.291.3.335","volume":"291","author":"SH Saydah","year":"2004","unstructured":"Saydah, S. H., Fradkin, J. & Cowie, C. C. Poor control of risk factors for vascular disease among adults with previously diagnosed diabetes. JAMA 291, 335\u2013342. https:\/\/doi.org\/10.1001\/jama.291.3.335 (2004).","journal-title":"JAMA"},{"key":"68640_CR10","doi-asserted-by":"publisher","first-page":"e112639","DOI":"10.1371\/journal.pone.0112639","volume":"9","author":"Y Jahangiri-Noudeh","year":"2014","unstructured":"Jahangiri-Noudeh, Y. et al. Trends in cardiovascular disease risk factors in people with and without diabetes mellitus: a Middle Eastern cohort study. PLoS ONE 9, e112639. https:\/\/doi.org\/10.1371\/journal.pone.0112639 (2014).","journal-title":"PLoS ONE"},{"key":"68640_CR11","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/1476-511X-13-20","volume":"13","author":"M Kheirandish","year":"2014","unstructured":"Kheirandish, M. et al. Secular trends in serum lipid levels of a Middle Eastern adult population; 10 years follow up in Tehran lipid and glucose study. Lipids Health Dis. 13, 20. https:\/\/doi.org\/10.1186\/1476-511X-13-20 (2014).","journal-title":"Lipids Health Dis."},{"key":"68640_CR12","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1111\/ggi.13154","volume":"18","author":"A Eslami","year":"2018","unstructured":"Eslami, A., Lotfaliany, M., Akbarpour, S., Azizi, F. & Hadaegh, F. Trend of cardiovascular risk factors in the older Iranian population: 2002\u20132014. Geriatrics Gerontol. Int. 18, 130\u2013137. https:\/\/doi.org\/10.1111\/ggi.13154 (2018).","journal-title":"Geriatrics Gerontol. Int."},{"key":"68640_CR13","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1016\/S0140-6736(10)62038-7","volume":"377","author":"F Farzadfar","year":"2011","unstructured":"Farzadfar, F. et al. National, regional, and global trends in serum total cholesterol since 1980: systematic analysis of health examination surveys and epidemiological studies with 321 country-years and 3.0 million participants. Lancet 377, 578\u2013586. https:\/\/doi.org\/10.1016\/S0140-6736(10)62038-7 (2011).","journal-title":"Lancet"},{"key":"68640_CR14","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/s0140-6736(16)31919-5","volume":"389","author":"B Zhou","year":"2017","unstructured":"Zhou, B. et al. Worldwide trends in blood pressure from 1975 to 2015: a pooled analysis of 1479 population-based measurement studies with 19\u00b71 million participants. Lancet 389, 37\u201355. https:\/\/doi.org\/10.1016\/s0140-6736(16)31919-5 (2017).","journal-title":"Lancet"},{"key":"68640_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(19)30179-2","author":"F Azizi","year":"2019","unstructured":"Azizi, F. et al. Metabolic health in the Middle East and north Africa. Lancet Diabetes Endocrinol. https:\/\/doi.org\/10.1016\/S2213-8587(19)30179-2 (2019).","journal-title":"Lancet Diabetes Endocrinol."},{"key":"68640_CR16","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1186\/s12889-017-4921-4","volume":"17","author":"X Sun","year":"2017","unstructured":"Sun, X. & Du, T. Trends in cardiovascular risk factors among U.S. men and women with and without diabetes, 1988\u20132014. BMC Public Health 17, 893. https:\/\/doi.org\/10.1186\/s12889-017-4921-4 (2017).","journal-title":"BMC Public Health"},{"key":"68640_CR17","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1161\/circulationaha.108.846519","volume":"120","author":"SR Preis","year":"2009","unstructured":"Preis, S. R. et al. Trends in cardiovascular disease risk factors in individuals with and without diabetes mellitus in the Framingham Heart Study. Circulation 120, 212\u2013220. https:\/\/doi.org\/10.1161\/circulationaha.108.846519 (2009).","journal-title":"Circulation"},{"key":"68640_CR18","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.pcd.2013.04.010","volume":"7","author":"S Samaranayaka","year":"2013","unstructured":"Samaranayaka, S. & Gulliford, M. C. Trends in cardiovascular risk factors among people with diabetes in a population based study, Health Survey for England 1994\u20132009. Primary Care Diabetes 7, 193\u2013198. https:\/\/doi.org\/10.1016\/j.pcd.2013.04.010 (2013).","journal-title":"Primary Care Diabetes"},{"key":"68640_CR19","doi-asserted-by":"publisher","first-page":"e0124817","DOI":"10.1371\/journal.pone.0124817","volume":"10","author":"C Karam","year":"2015","unstructured":"Karam, C. et al. Trends in cardiovascular disease risk factor prevalence and estimated 10-year cardiovascular risk scores in a large untreated French Urban Population: the CARVAR 92 study. PLoS ONE 10, e0124817. https:\/\/doi.org\/10.1371\/journal.pone.0124817 (2015).","journal-title":"PLoS ONE"},{"key":"68640_CR20","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1161\/circulationaha.113.002424","volume":"128","author":"J Hata","year":"2013","unstructured":"Hata, J. et al. Secular trends in cardiovascular disease and its risk factors in Japanese: half-century data from the Hisayama Study (1961\u20132009). Circulation 128, 1198\u20131205. https:\/\/doi.org\/10.1161\/circulationaha.113.002424 (2013).","journal-title":"Circulation"},{"key":"68640_CR21","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.1001\/jama.294.14.1773","volume":"294","author":"MD Carroll","year":"2005","unstructured":"Carroll, M. D. et al. Trends in serum lipids and lipoproteins of adults, 1960\u20132002. JAMA 294, 1773\u20131781 (2005).","journal-title":"JAMA"},{"key":"68640_CR22","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1001\/jama.2012.13260","volume":"308","author":"MD Carroll","year":"2012","unstructured":"Carroll, M. D., Kit, B. K., Lacher, D. A., Shero, S. T. & Mussolino, M. E. Trends in lipids and lipoproteins in US adults, 1988\u20132010. JAMA 308, 1545\u20131554 (2012).","journal-title":"JAMA"},{"key":"68640_CR23","doi-asserted-by":"publisher","first-page":"e1002751","DOI":"10.1371\/journal.pmed.1002751","volume":"16","author":"J Manne-Goehler","year":"2019","unstructured":"Manne-Goehler, J. et al. Health system performance for people with diabetes in 28 low-and middle-income countries: A cross-sectional study of nationally representative surveys. PLoS Med. 16, e1002751 (2019).","journal-title":"PLoS Med."},{"key":"68640_CR24","unstructured":"Torabi, P., Zare, F., Shekholeslam, R. & Safavi, S. M. in 12th Nutritional Congress. Tabriz; Iran."},{"key":"68640_CR25","first-page":"29","volume":"9","author":"N Mohammadifard","year":"2013","unstructured":"Mohammadifard, N. et al. Improvement of dietary oil consumption following a community trial in a developing country: The role of translational research in health promotion. ARYA Atherosclerosis 9, 29\u201337 (2013).","journal-title":"ARYA Atherosclerosis"},{"key":"68640_CR26","doi-asserted-by":"publisher","first-page":"163","DOI":"10.5539\/gjhs.v8n12p163","volume":"8","author":"M Jafari","year":"2016","unstructured":"Jafari, M., Mohammadi, M., Ghazizadeh, H. & Nakhaee, N. Feasibility and outcome of reducing salt in bread: a community trial in Southern Iran. Global J. Health Sci. 8, 163. https:\/\/doi.org\/10.5539\/gjhs.v8n12p163 (2016).","journal-title":"Global J. Health Sci."},{"key":"68640_CR27","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1123\/jpah.8.1.27","volume":"8","author":"A Esteghamati","year":"2011","unstructured":"Esteghamati, A. et al. Physical activity in Iran: results of the third national surveillance of risk factors of non-communicable diseases (SuRFNCD-2007). J. Phys. Activity Health 8, 27\u201335 (2011).","journal-title":"J. Phys. Activity Health"},{"key":"68640_CR28","first-page":"243","volume":"2","author":"AA Momenan","year":"2011","unstructured":"Momenan, A. A., Delshad, M., Mirmiran, P., Ghanbarian, A. & Azizi, F. Leisure time physical activity and its determinants among adults in Tehran: Tehran Lipid and Glucose Study. Int. J. Prevent. Med. 2, 243\u2013251 (2011).","journal-title":"Int. J. Prevent. Med."},{"key":"68640_CR29","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1161\/01.hyp.37.2.187","volume":"37","author":"P Primatesta","year":"2001","unstructured":"Primatesta, P., Falaschetti, E., Gupta, S., Marmot, M. G. & Poulter, N. R. Association between smoking and blood pressure: evidence from the health survey for England. Hypertension 37, 187\u2013193. https:\/\/doi.org\/10.1161\/01.hyp.37.2.187 (2001).","journal-title":"Hypertension"},{"key":"68640_CR30","first-page":"273","volume":"50","author":"A Venkatesan","year":"2006","unstructured":"Venkatesan, A., Hemalatha, A., Bobby, Z., Selvaraj, N. & Sathiyapriya, V. Effect of smoking on lipid profile and lipid peroxidation in normal subjects. Indian J. Physiol. Pharmacol. 50, 273\u2013278 (2006).","journal-title":"Indian J. Physiol. Pharmacol."},{"key":"68640_CR31","doi-asserted-by":"publisher","first-page":"e102563","DOI":"10.1371\/journal.pone.0102563","volume":"9","author":"A Derakhshan","year":"2014","unstructured":"Derakhshan, A. et al. Sex specific incidence rates of type 2 diabetes and its risk factors over 9 years of follow-up: Tehran Lipid and Glucose Study. PLoS ONE 9, e102563. https:\/\/doi.org\/10.1371\/journal.pone.0102563 (2014).","journal-title":"PLoS ONE"},{"key":"68640_CR32","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.2337\/diacare.18.9.1270","volume":"18","author":"JM Mooy","year":"1995","unstructured":"Mooy, J. M. et al. Prevalence and determinants of glucose intolerance in a Dutch caucasian population. The Hoorn Study. Diabetes Care 18, 1270\u20131273. https:\/\/doi.org\/10.2337\/diacare.18.9.1270 (1995).","journal-title":"Diabetes Care"},{"key":"68640_CR33","doi-asserted-by":"publisher","first-page":"M252","DOI":"10.1093\/geronj\/49.6.m252","volume":"49","author":"PW Wilson","year":"1994","unstructured":"Wilson, P. W., Anderson, K. M., Harris, T., Kannel, W. B. & Castelli, W. P. Determinants of change in total cholesterol and HDL-C with age: the Framingham Study. J. Gerontol. 49, M252-257. https:\/\/doi.org\/10.1093\/geronj\/49.6.m252 (1994).","journal-title":"J. Gerontol."},{"key":"68640_CR34","first-page":"80","volume":"12","author":"F Azizi","year":"2002","unstructured":"Azizi, F. et al. Determinants of serum HDL-C level in a Tehran urban population: the Tehran Lipid and Glucose Study. Nutr. Metab. Cardiovasc. Dis. NMCD 12, 80\u201389 (2002).","journal-title":"Nutr. Metab. Cardiovasc. Dis. NMCD"},{"key":"68640_CR35","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1186\/1471-2458-12-1064","volume":"12","author":"M Farahmand","year":"2012","unstructured":"Farahmand, M., Tehrani, F. R., Amiri, P. & Azizi, F. Barriers to healthy nutrition: perceptions and experiences of Iranian women. BMC Public Health 12, 1064. https:\/\/doi.org\/10.1186\/1471-2458-12-1064 (2012).","journal-title":"BMC Public Health"},{"key":"68640_CR36","first-page":"390","volume":"17","author":"B Enjezab","year":"2012","unstructured":"Enjezab, B., Farajzadegan, Z., Taleghani, F. & Aflatoonian, A. Internal motivations and barriers effective on the healthy lifestyle of middle-aged women: A qualitative approach. Iran. J. Nurs. Midwifery Res. 17, 390\u2013398 (2012).","journal-title":"Iran. J. Nurs. Midwifery Res."},{"key":"68640_CR37","first-page":"131","volume":"1","author":"R Kelishadi","year":"2010","unstructured":"Kelishadi, R. et al. Barriers to physical activity in a population-based sample of children and adolescents in Isfahan, Iran. Int. J. Prevent. Med. 1, 131\u2013137 (2010).","journal-title":"Int. J. Prevent. Med."},{"key":"68640_CR38","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.appet.2015.02.025","volume":"89","author":"M Farahmand","year":"2015","unstructured":"Farahmand, M. et al. What are the main barriers to healthy eating among families? A qualitative exploration of perceptions and experiences of Tehranian men. Appetite 89, 291\u2013297. https:\/\/doi.org\/10.1016\/j.appet.2015.02.025 (2015).","journal-title":"Appetite"},{"key":"68640_CR39","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1016\/j.amepre.2010.03.003","volume":"38","author":"H Harati","year":"2010","unstructured":"Harati, H. et al. Reduction in incidence of type 2 diabetes by lifestyle intervention in a middle eastern community. Am. J. Prevent. Med. 38, 628\u2013636 e621. https:\/\/doi.org\/10.1016\/j.amepre.2010.03.003 (2010).","journal-title":"Am. J. Prevent. Med."},{"key":"68640_CR40","doi-asserted-by":"publisher","first-page":"39","DOI":"10.2471\/blt.07.049841","volume":"87","author":"N Sarrafzadegan","year":"2009","unstructured":"Sarrafzadegan, N. et al. Do lifestyle interventions work in developing countries? Findings from the Isfahan Healthy Heart Program in the Islamic Republic of Iran. Bull. World Health Organ. 87, 39\u201350. https:\/\/doi.org\/10.2471\/blt.07.049841 (2009).","journal-title":"Bull. World Health Organ."},{"key":"68640_CR41","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1016\/j.aogh.2015.10.003","volume":"81","author":"S Noshad","year":"2015","unstructured":"Noshad, S., Afarideh, M., Heidari, B., Mechanick, J. I. & Esteghamati, A. Diabetes care in Iran: where we stand and where we are headed. Ann. Global Health 81, 839\u2013850. https:\/\/doi.org\/10.1016\/j.aogh.2015.10.003 (2015).","journal-title":"Ann. Global Health"},{"key":"68640_CR42","first-page":"146","volume":"40","author":"E Shakibazadeh","year":"2011","unstructured":"Shakibazadeh, E. et al. Patients\u2019 perspectives on factors that influence diabetes self-care. Iran. J. Public Health 40, 146\u2013158 (2011).","journal-title":"Iran. J. Public Health"},{"key":"68640_CR43","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1093\/heapro\/dav006","volume":"31","author":"E Shakibazadeh","year":"2016","unstructured":"Shakibazadeh, E., Bartholomew, L. K., Rashidian, A. & Larijani, B. Persian Diabetes Self-Management Education (PDSME) program: evaluation of effectiveness in Iran. Health Promot. Int. 31, 623\u2013634. https:\/\/doi.org\/10.1093\/heapro\/dav006 (2016).","journal-title":"Health Promot. Int."},{"key":"68640_CR44","doi-asserted-by":"publisher","first-page":"S114","DOI":"10.1016\/j.dsx.2015.10.006","volume":"10","author":"M Niroomand","year":"2016","unstructured":"Niroomand, M. et al. Diabetes knowledge, attitude and practice (KAP) study among Iranian in-patients with type-2 diabetes: a cross-sectional study. Diabetes Metab. Syndr 10, S114-119. https:\/\/doi.org\/10.1016\/j.dsx.2015.10.006 (2016).","journal-title":"Diabetes Metab. Syndr"},{"key":"68640_CR45","unstructured":"World Health Organization. NCDs | STEPwise approach to surveillance (STEPS), <https:\/\/www.who.int\/ncds\/surveillance\/steps\/en\/> (2019)."},{"key":"68640_CR46","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/1476-511X-9-52","volume":"9","author":"Y Chen","year":"2010","unstructured":"Chen, Y. et al. A modified formula for calculating low-density lipoprotein cholesterol values. Lipids Health Dis. 9, 52. https:\/\/doi.org\/10.1186\/1476-511X-9-52 (2010).","journal-title":"Lipids Health Dis."},{"key":"68640_CR47","doi-asserted-by":"publisher","first-page":"5","DOI":"10.2337\/cd16-0067","volume":"35","author":"A American Diabetes","year":"2017","unstructured":"American Diabetes, A. Standards of medical care in diabetes-2017 abridged for primary care providers. Clin. Diabetes 35, 5\u201326. https:\/\/doi.org\/10.2337\/cd16-0067 (2017).","journal-title":"Clin. Diabetes"},{"key":"68640_CR48","doi-asserted-by":"publisher","first-page":"S61","DOI":"10.2337\/dc19-S006","volume":"42","author":"AD Association","year":"2019","unstructured":"Association, A. D. 6. Glycemic targets: standards of medical care in diabetes\u20142019. Diabetes Care 42, S61\u2013S70 (2019).","journal-title":"Diabetes Care"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-68640-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-68640-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-68640-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T13:20:32Z","timestamp":1670332832000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-68640-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,16]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["68640"],"URL":"https:\/\/doi.org\/10.1038\/s41598-020-68640-9","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,16]]},"assertion":[{"value":"24 January 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 June 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"11724"}}